A Study of Rifabutin and MK-4646 in Healthy Participants (MK-4646-004)
Clinical trial NCT07199452 · COMPLETED
Trial details
- NCT number
- NCT07199452
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-28
- Primary completion
- 2025-12-27
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.